The All of Us Research Program launched a Speaker Series in partnership with the National Library of Medicine on Thursday, March 14, 2019. The inaugural talk was by National Institutes of Health Director Dr. Francis Collins. Dr. Collins discusses the importance of All of Us, how far the research program has come, provide a preview of the program’s future, and takes questions from viewer.
Continue reading
Author Archive: AZBio
Evidence Links Hookah, Use to Increased Risk of Heart Disease
A new study published by the American Heart Association revealed that those who smoke hookah have an increased risk of heart disease.Continue reading
Endometriosis Awareness Month: Here’s What You Need to Know
OB/GYN Discusses Endometriosis Risks, Diagnosis and Treatment Options. Continue reading
Barrow Neurological Institute honored as Exceptional Innovator
Barrow Neurological Institute earned the Greater Phoenix Chamber’s 2019 IMPACT Awards for Exceptional Innovator.Continue reading
Conducting research: Exploring charge flow through proteins
Among the zoo of biomolecules essential to life, proteins are the most startlingly varied and versatile.Continue reading
Implantable ‘Tea Bag’ in Development Releases Insulin for Children with Diabetes
A $1.2 million grant from the JDRF will support University of Arizona researchers as they continue to perfect and test an implantable “tea bag” that senses glucose levels and automatically releases insulin when needed.Continue reading
SynCardia Announces Promotion of Don Webber to CEO
Don Webber brings more than 25 years of medical device management expertiseContinue reading
FDA Approves Genentech’s Kadcyla for Adjuvant Treatment of People with HER2-Positive Early Breast Cancer with Residual Invasive Disease After Neoadjuvant Treatment
– Approval based on data showing Kadcyla cut the risk of disease recurring by half compared to Herceptin in the adjuvant setting for specific patients with HER2-positive early breast cancer –
– Application approved under FDA’s Real-Time Oncology Review pilot program –
TGen plays key role in identifying foothold for leveraging cancer cell weakness
Nationwide effort reveals potential treatment option for pancreatic cancerContinue reading